Antonio Giordano, Breast Medical Oncologist at Dana-Farber Cancer Institute, shared a post on X:
“Phase I clinical trials are the engine of progress in cancer therapeutics. The incredible team at Dana-Farber’s CCTI has driven meaningful advances for every patient enrolled. Wishing you all a very happy holiday season from CCTI, very proud of every team member.”
More posts featuring Antonio Giordano.